Note to Providers:
Ixiaro: Boosters and Patients Younger than 17
The 12/7/2011 Japanese encephalitis VIS advises patients to ask their doctor if they want additional information about either vaccination of patients younger than 17 years of age (for which Ixiaro is not licensed) or the need for booster doses.
Information on these topics may be found in MMWR articles published in 2011:
- Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine [i.e., Ixiaro] — Advisory Committee on Immunization Practices, 2011
- Update on Japanese Encephalitis Vaccine for Children — United States, May 2011
This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.
File Formats: All viewers, players, and plug-ins used on this site can be downloaded from the file formats page. (For example: Adobe Acrobat Reader for pdf files, Windows Media Player for audio and video files, PowerPoint Viewer for presentation slides, etc.)
Content last reviewed on December 7, 2011
Content Source: National Center for Immunization and Respiratory Diseases